Has Maica Javien received payments from drug or device companies?

Yes. Drug and device makers reported $2,735 in general payments to Maica Javien across 107 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maica Javien did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maica Javien come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maica Javien

Family · Fullerton, CANPI 1255086443

Payments from drug & device makers

$2,735in general payments, 2019–2025

Across 107 payments — averaging $25.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$712
Ardelyx, Inc.$389
AbbVie$376
Gilead$214
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$213
Intercept Pharmaceuticals, Inc.$152
plus $679 from 12 others

What the payments were for

Food & beverage$2,65197%
Education$843%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	28	$712
Ardelyx, Inc.	14	$389
AbbVie	13	$376
Gilead	2	$214
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	14	$213
Intercept Pharmaceuticals, Inc.	8	$152
Ipsen Biopharmaceuticals, Inc	5	$143
Redhill Biopharma Inc.	6	$142
Braintree Laboratories, Inc.	3	$59
Fresenius Kabi USA, LLC	2	$58
Takeda Pharmaceuticals U.S.A., Inc.	3	$51
Sanofi	2	$44
Boston Scientific	1	$42
Madrigal Pharmaceuticals	2	$36
Phathom Pharmaceuticals, Inc.	1	$28
QOL Medical, LLC	1	$26
Azurity Pharmaceuticals, Inc.	1	$26
Lilly USA, LLC	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,735 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.

See all family providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
TrulancePlecanatide	39	$21,015
LinzessLinaclotide	24	$12,767
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl	224	$3,482
Dexlansoprazole DrDexlansoprazole	12	$2,359
Pantoprazole Sodium	105	$1,388
Omeprazole	149	$1,021
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl	66	$1,001
Dicyclomine Hcl	58	$863
Famotidine	37	$617
Desipramine Hcl	33	$523
Sucralfate	16	$518
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl	15	$291
Tenofovir Disoproxil Fumarate	12	$200
Metronidazole	20	$190
Doxycycline Hyclate	16	$138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance	$213	$21,01539 claims
AbbVieLinzess	$376	$12,76724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.

Other family in Fullerton

Lori RobertsonChino Hills$475K
Annette ShonLos Angeles$406K
Nancy GardettoSan Diego$394K
Lisa HigginsHanford$311K
Jennifer TougasBakersfield$302K
Kim SchaferSacramento$288K
Dawn MeyerSan Diego$270K
Jennifer KangCerritos$255K
Jenine StoneEscondido$231K
Erin DwyerSan Diego$189K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →